Vetoquinol (VETO) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.026x

Based on the latest financial reports, Vetoquinol (VETO) has a cash flow conversion efficiency ratio of 0.026x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€14.72 Million ≈ $17.21 Million USD) by net assets (€567.53 Million ≈ $663.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Vetoquinol stock valuation for the company's overall valuation and market capitalisation.

Vetoquinol - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how Vetoquinol's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Vetoquinol stock price today for real-time trading data and today's change.

Vetoquinol Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vetoquinol ranked by their cash flow conversion efficiency. Review VETO free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Jiangsu Aidea Pharmaceutical Co Ltd
SHG:688488
0.004x
Supalai Public Company Limited
BK:SPALI-R
0.012x
Deluxe Corporation
NYSE:DLX
0.076x
Ye Chiu Metal Recycling China Ltd
SHG:601388
-0.026x
FERRETTI S.P.A. O.N.
F:F3T1
N/A
WUS Printed Circuit Co Ltd
TW:2316
-0.028x
Grupo Herdez S.A.B. de C.V
MX:HERDEZ
-0.014x
Shunfa Hengye Corp
SHE:000631
0.000x

Annual Cash Flow Conversion Efficiency for Vetoquinol (2004–2024)

The table below shows the annual cash flow conversion efficiency of Vetoquinol from 2004 to 2024. Also see VETO asset base for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €575.93 Million
≈ $673.33 Million
€85.83 Million
≈ $100.34 Million
0.149x -12.13%
2023-12-31 €527.11 Million
≈ $616.25 Million
€89.39 Million
≈ $104.51 Million
0.170x +30.77%
2022-12-31 €484.66 Million
≈ $566.62 Million
€62.85 Million
≈ $73.48 Million
0.130x -36.20%
2021-12-31 €441.35 Million
≈ $515.99 Million
€89.72 Million
≈ $104.89 Million
0.203x -18.05%
2020-12-31 €371.83 Million
≈ $434.71 Million
€92.23 Million
≈ $107.83 Million
0.248x +84.03%
2019-12-31 €385.98 Million
≈ $451.25 Million
€52.02 Million
≈ $60.82 Million
0.135x +29.18%
2018-12-31 €363.08 Million
≈ $424.48 Million
€37.88 Million
≈ $44.29 Million
0.104x -15.03%
2017-12-31 €335.73 Million
≈ $392.50 Million
€41.23 Million
≈ $48.20 Million
0.123x -10.05%
2016-12-31 €316.48 Million
≈ $369.99 Million
€43.20 Million
≈ $50.51 Million
0.137x +1.61%
2015-12-31 €289.49 Million
≈ $338.45 Million
€38.90 Million
≈ $45.47 Million
0.134x -12.68%
2014-12-31 €268.40 Million
≈ $313.78 Million
€41.30 Million
≈ $48.28 Million
0.154x +29.18%
2013-12-31 €235.96 Million
≈ $275.86 Million
€28.11 Million
≈ $32.86 Million
0.119x -20.61%
2012-12-31 €228.01 Million
≈ $266.57 Million
€34.21 Million
≈ $39.99 Million
0.150x +5.70%
2011-12-31 €211.29 Million
≈ $247.02 Million
€29.99 Million
≈ $35.06 Million
0.142x -23.87%
2010-12-31 €184.27 Million
≈ $215.43 Million
€34.36 Million
≈ $40.17 Million
0.186x -27.85%
2009-12-31 €154.95 Million
≈ $181.15 Million
€40.05 Million
≈ $46.82 Million
0.258x +61.72%
2008-12-31 €137.05 Million
≈ $160.23 Million
€21.90 Million
≈ $25.61 Million
0.160x -45.09%
2007-12-31 €127.87 Million
≈ $149.49 Million
€37.22 Million
≈ $43.51 Million
0.291x +38.50%
2006-12-31 €111.15 Million
≈ $129.94 Million
€23.36 Million
≈ $27.31 Million
0.210x -39.22%
2005-12-31 €86.82 Million
≈ $101.50 Million
€30.01 Million
≈ $35.09 Million
0.346x +19.09%
2004-12-31 €71.38 Million
≈ $83.45 Million
€20.72 Million
≈ $24.23 Million
0.290x --

About Vetoquinol

PA:VETO France Drug Manufacturers - Specialty & Generic
Market Cap
$1.06 Billion
€902.66 Million EUR
Market Cap Rank
#8773 Global
#140 in France
Share Price
€76.50
Change (1 day)
+0.66%
52-Week Range
€66.10 - €91.00
All Time High
€149.34
About

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal … Read more